Medulloblastoma screening: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Medulloblastoma}} | {{Medulloblastoma}} | ||
{{CMG}} {{AE}}{{HL}} | {{CMG}} {{AE}}{{sali}}{{HL}} | ||
==Overview== | ==Overview== | ||
Latest revision as of 14:41, 2 July 2019
|
Medulloblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case studies |
|
Medulloblastoma screening On the Web |
|
American Roentgen Ray Society Images of Medulloblastoma screening |
|
Risk calculators and risk factors for Medulloblastoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Syed Musadiq Ali M.B.B.S.[2]Haytham Allaham, M.D. [3]
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for medulloblastoma.[1]
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for medulloblastoma.[1]
References
- ↑ 1.0 1.1 Recommendations. US preventive services task force(2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=medulloblastoma Accessed on September, 28th 2015